1
Jacobs, Maartje S, Schouten, Jeroen F, de Boer, Pieter T, Hoffmann, Mikael, Levin, Lars-Åke, Postma, Maarten J
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
Veröffentlicht in: Jacobs , M S , Schouten , J F , de Boer , P T , Hoffmann , M , Levin , L-Å & Postma , M J 2018 , ' Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands ' , Current Medical Research and Opinion , vol. 34 , no. 10 , pp. 1839-1847 . https://doi.org/10.1080/03007995.2018.1459528;
2018
2
Smits, E., Andreotti, F., Houben, E., Crijns, H.J.G.M., Haas, S., Spentzouris, G., Schink, T., Gini, R., Bartolini, C., Penning-van Beest, F., Herings, R.
Veröffentlicht in: Smits , E , Andreotti , F , Houben , E , Crijns , H J G M , Haas , S , Spentzouris , G , Schink , T , Gini , R , Bartolini , C , Penning-van Beest , F & Herings , R 2022 , ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany ' , Drugs-Real World Outcomes , vol. 9 , no. 2 , pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w;
2022
Veröffentlicht in: Smits , E , Andreotti , F , Houben , E , Crijns , H J G M , Haas , S , Spentzouris , G , Schink , T , Gini , R , Bartolini , C , Penning-van Beest , F & Herings , R 2022 , ' Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany ' , Drugs-Real World Outcomes , vol. 9 , no. 2 , pp. 199-209 . https://doi.org/10.1007/s40801-021-00289-w;
2022
3
Pisters, R., van Vugt, S. P. G., Brouwer, M. A., Elvan, A., ten Holt, W. L., Zwart, P. A. G., Kirchhof, P., Crijns, H. J. G. M., Hemels, M. E. W.
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
Veröffentlicht in: Pisters , R , van Vugt , S P G , Brouwer , M A , Elvan , A , ten Holt , W L , Zwart , P A G , Kirchhof , P , Crijns , H J G M & Hemels , M E W 2017 , ' Real-life use of Rivaroxaban in the Netherlands : data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry ' , Netherlands Heart Journal , vol. 25 , no. 10 , pp. 551-558 . https://doi.org/10.1007/s12471-017-1009-9;
2017
4
5
Chu, Gordon, Seelig, Jaap, Trinks-Roerdink, Emmy M., van Alem, Anouk P., Alings, Marco, van den Bemt, Bart, Boersma, Lucas V. A., Brouwer, Marc A., Cannegieter, Suzanne C., ten Cate, Hugo, Kirchhof, Charles J. H. J., Crijns, Harry J. G. M., van Dijk, Ewoud J., Elvan, Arif, van Gelder, Isabelle C., de Groot, Joris R., den Hartog, Frank R., de Jong, Jonas S. S. G., de Jong, Sylvie, Klok, Frederikus A., Lenderink, Timo, Luermans, Justin G., Meeder, Joan G., Pisters, Ron, Polak, Peter, Rienstra, Michiel, Smeets, Frans, Tahapary, Giovanni J. M., Theunissen, Luc, Tieleman, Robert G., Trines, Serge A., van der Voort, Pepijn, Geersing, Geert-Jan, Rutten, Frans H., Hemels, Martin Ew, Huisman, Menno
Veröffentlicht in: Chu , G , Seelig , J , Trinks-Roerdink , E M , van Alem , A P , Alings , M , van den Bemt , B , Boersma , L V A , Brouwer , M A , Cannegieter , S C , ten Cate , H , Kirchhof , C J H J , Crijns , H J G M , van Dijk , E J , Elvan , A , van Gelder , I C , de Groot , J R , den Hartog , F R , de Jong , J S S G , de Jong , S , Klok , F A , Lenderink , T , Luermans , J G , Meeder , J G , Pisters , R , Polak , P , Rienstra , M , Smeets , F , Tahapary , G J M , Theunissen , L , Tieleman , R G , Trines , S A , van der Voort , P , Geersing , G-J , Rutten , F H , Hemels , M E & Huisman , M 2020 , ' Design and rationale of DUTCH-AF : a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation ' , BMJ Open , vol. 10 , no. 8 , 036220 . https://doi.org/10.1136/bmjopen-2019-036220;
2020
Veröffentlicht in: Chu , G , Seelig , J , Trinks-Roerdink , E M , van Alem , A P , Alings , M , van den Bemt , B , Boersma , L V A , Brouwer , M A , Cannegieter , S C , ten Cate , H , Kirchhof , C J H J , Crijns , H J G M , van Dijk , E J , Elvan , A , van Gelder , I C , de Groot , J R , den Hartog , F R , de Jong , J S S G , de Jong , S , Klok , F A , Lenderink , T , Luermans , J G , Meeder , J G , Pisters , R , Polak , P , Rienstra , M , Smeets , F , Tahapary , G J M , Theunissen , L , Tieleman , R G , Trines , S A , van der Voort , P , Geersing , G-J , Rutten , F H , Hemels , M E & Huisman , M 2020 , ' Design and rationale of DUTCH-AF : a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation ' , BMJ Open , vol. 10 , no. 8 , 036220 . https://doi.org/10.1136/bmjopen-2019-036220;
2020
6
Jacobs, M S, van Leent, M W J, Tieleman, R G, Jansman, F G A, Cao, Q, Postma, M J, van Hulst, M
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
Veröffentlicht in: Jacobs , M S , van Leent , M W J , Tieleman , R G , Jansman , F G A , Cao , Q , Postma , M J & van Hulst , M 2017 , ' Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 12 , pp. 1231-1236 . https://doi.org/10.1080/13696998.2017.1363766;
2017
7
van Hulst, Marinus, Stevanovic, Jelena, Jacobs, Maartje S, Tieleman, Robert G, Kappelhoff, Bregt, Postma, Maarten J
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
Veröffentlicht in: van Hulst , M , Stevanovic , J , Jacobs , M S , Tieleman , R G , Kappelhoff , B & Postma , M J 2018 , ' The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands ' , Journal of Medical Economics , vol. 21 , no. 1 , pp. 38-46 . https://doi.org/10.1080/13696998.2017.1372222;
2018
8
9
Le, H.H., Pechlivanoglou, P., Postma, M.J.
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013
Veröffentlicht in: Le , H H , Pechlivanoglou , P & Postma , M J 2013 , ' Indirect treatment comparison and economic evaluation of novel oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in the Netherlands ' , Value in Health , vol. 16 , no. 7 , pp. A514 . https://doi.org/10.1016/j.jval.2013.08.1213;
2013